Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.4.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.4.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.4.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.273EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.273ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.273ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.273EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.273EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.273ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.273ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.13 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.13 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.13 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.4.13 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.4.13 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.4.13 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.13 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.13 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.358EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.358EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.358ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.358ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.358EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.358EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.358ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.358ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used